Bioventix PLC (AIM:BVXP)
London · Delayed Price · Currency is GBP · Price in GBX 1,595.00
+45.00 (2.90%)
Sep 25, 2026, 2:53 PM GMT
Bioventix Market Cap
Bioventix has a market cap or net worth of 80.99 million as of September 25, 2026. Its market cap has decreased by -38.00% in one year.
Market Cap
80.99M
Enterprise Value
75.68M
Revenue
12.54M
Ranking
n/a
PE Ratio
11.03
Stock Price
1,595.00
ChartMarket Cap Chart
Since April 8, 2010, Bioventix's market cap has increased from 9.85M to 80.99M, an increase of 722.39%. That is a compound annual growth rate of 13.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 80.99M | -18.64% |
| Dec 31, 2025 | 99.53M | -39.94% |
| Dec 31, 2024 | 165.72M | -26.16% |
| Dec 29, 2023 | 224.45M | 7.98% |
| Dec 30, 2022 | 207.85M | 17.35% |
| Dec 31, 2021 | 177.12M | -22.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PureTech Health | 296.67M |
| Scancell Holdings | 118.80M |
| 4basebio | 86.24M |
| Faron Pharmaceuticals Oy | 72.29M |
| Poolbeg Pharma | 68.71M |
| Ondine Biomedical | 55.85M |
| Sareum Holdings | 44.34M |
| Arecor Therapeutics | 33.04M |